Correlations among different platelet aggregation pathways in a group of healthy volunteers

Platelet aggregation is a complicated process mediated by different signaling pathways. As the process is highly complex and apparently redundant, the relationships between these pathways are not yet fully known. The aim of this project was to study the interconnections among seven different aggrega...

Full description

Saved in:
Bibliographic Details
Published in:Platelets (Edinburgh) 2024-12, Vol.35 (1), p.2336093-2336093
Main Authors: Carazo, Alejandro, Hrubša, Marcel, Konečný, Lukáš, Gunaseelan, Catherine, Fadraersada, Jaka, Skořepa, Pavel, Paclíková, Markéta, Musil, František, Karlíčková, Jana, Javorská, Lenka, Matoušová, Kateřina, Kujovská Krčmová, Lenka, Šmahelová, Alena, Blaha, Vladimír, Mladenka, Přemysl
Format: Article
Language:English
Subjects:
Antiplatelet drug
arachidonic acid
healthy volunteer
platelet aggregation
signaling pathway
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Platelet aggregation is a complicated process mediated by different signaling pathways. As the process is highly complex and apparently redundant, the relationships between these pathways are not yet fully known. The aim of this project was to study the interconnections among seven different aggregation pathways in a group of 53 generally healthy volunteers aged 20 to 66 years. Platelet aggregation was induced with thrombin receptor activating peptide 6 (TRAP), arachidonic acid (AA), platelet activating factor 16 (PAF), ADP, collagen, thromboxane A analogue U46619 or ristocetin (platelet agglutination) in fasting blood samples according to standardized timetable protocol. Additionally, some samples were pre-treated with known clinically used antiplatelet drugs (vorapaxar, ticagrelor or acetylsalicylic acid (ASA)). Significant correlations among all used inducers were detected (Pearson correlation coefficients (r ): 0.3 to 0.85). Of all the triggers, AA showed to be the best predictor of the response to other inducers with r ranging from 0.66 to 0.85. Interestingly, the antiplatelet response to ticagrelor strongly predicted the response to unrelated drug vorapaxar (r  = 0.71). Our results indicate that a response to one inducer can predict the response for other triggers or even to an antiplatelet drug. These data are useful for future testing but should be also confirmed in patients.
ISSN:0953-7104
1369-1635
DOI:10.1080/09537104.2024.2336093